Joint scientific opinion assesses the likelihood of swine-origin influenza A(H3N2) in the EU as low
The joint scientific opinion by three EU agencies assesses and advises on the possible risks posed by influenza A(H3N2)v virus for animal health and the potential implications for animal and human health.
WHO recommendations for influenza virus vaccine composition for the 2018 southern hemisphere influenza season
The World Health Organization (WHO) has recommended the composition of the trivalent influenza vaccine for the southern hemisphere winter 2018 influenza season in a report published 28 September 2017.
WHO recommendations for influenza virus vaccine composition for the 2018-2019 Northern hemisphere season
On 19-21 February 2018 the World Health Organization (WHO) agreed on the recommended composition of the trivalent influenza vaccine for the northern hemisphere 2018-2019 influenza season; A/Michigan/45/2015 (H1N1)pdm09-like virus, A/Singapore/INFIMH-16-0019/2016 (H3N2)-like virus, B/Colorado/06/2017-like virus (B/Victoria/2/87 lineage). The WHO recommendations are made with a knowledge of the currently circulating viruses globally. WHO recommended two changes, compared to the current trivalent and quadrivalent vaccines for the 2017–2018 season in the northern hemisphere influenza season.
WHO recommendation on influenza virus vaccines for the northern hemisphere 2012-2013 seasonArchived
One of the most important functions and outputs of the laboratory aspect of the Global Influenza Surveillance and Response System (GISRS) coordinated by WHO are biannual influenza vaccine strain selection meetings that take place each year around February and September. These scientific meetings make recommendations on the antigens to go into the influenza vaccines for the northern hemisphere (February meeting) and southern hemisphere seasons (September meeting).
UK parents’ decision-making about measles–mumps–rubella (MMR) vaccine 10 years after the MMR-autism controversy: A qualitative analysis
This study indicates, as others have previously, that trust in health professionals and vaccine policy is central to acceptance of MMR.
Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008
In this study, the authors have combined a household method and a school study design to assess VE against mumps as well as VE against mumps infectiousness by comparing secondary attack rates in households of vaccinated and unvaccinated cases.
Ferrets as experimental models of influenza in humans
A number of animal models have been used to study how influenza viruses may work in humans: mice, hamsters, guinea pigs, and both cotton rats (Sigmodon) and ordinary rats (Rattus).
Nasopharyngeal flora in children with acute otitis media before and after implementation of 7 valent pneumococcal conjugate vaccine in France
This study found a marked reduction in vaccine serotype carriage after PCV7 implementation. The overall pneumococcal, H. influenzae and S. aureus carriage decreased slightly, but not significantly.